Does INOTUZUMAB OZOGAMICIN Cause Hepatotoxicity? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Hepatotoxicity have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 1.4% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
33
Reports of Hepatotoxicity with INOTUZUMAB OZOGAMICIN
1.4%
of all INOTUZUMAB OZOGAMICIN reports
14
Deaths
1
Hospitalizations
How Dangerous Is Hepatotoxicity From INOTUZUMAB OZOGAMICIN?
Of the 33 reports, 14 (42.4%) resulted in death, 1 (3.0%) required hospitalization.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for INOTUZUMAB OZOGAMICIN.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Hepatotoxicity Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC